Clostridium difficile infection is a frequent but well-controlled event after hematopoietic cell transplantation()

Por Caimi, Paolo Fabrizio
Publicado no Rev Bras Hematol Hemoter (2015)

Genetic polymorphisms, chronic lymphocytic leukemia, and the future: are we there yet?

Por Caimi, Paolo F., de Lima, Marcos
Publicado em 2014

Cord Blood Transplantation: Can We Make it Better?

Por Metheny, Leland, Caimi, Paolo, de Lima, Marcos
Publicado em 2013

Bortezomib for the treatment of mantle cell lymphoma: an update

Por Hambley, Bryan, Caimi, Paolo F., William, Basem M.
Publicado no Ther Adv Hematol (2016)

Emerging Therapeutic Approaches For Multipotent Mesenchymal Stromal Cells (MSCs)

Por Caimi, Paolo F., Reese, Jane, Lee, Zhenghong, Lazarus, Hillard M.
Publicado em 2010

Isolated skin relapse of Philadelphia chromosome-positive acute lymphoblastic leukemia after allogeneic stem cell transplant

Por Ueda, Masumi, Silva, Carlos, Baer, Linda, Caimi, Paolo F., Cooper, Kevin, Honda, Kord, de Lima, Marcos
Publicado no Rev Bras Hematol Hemoter (2017)

Prognostic information and biological insights in chronic lymphocytic leukemia by high-resolution immunophenotypic analysis of ZAP70

Por Kaplan, David, Sun, Zhuoxin, Tallman, Martin S., Flinn, Ian W., Xiao, Wenbin, Caimi, Paolo F., Kaye, Nicholas M., Lazarus, Hillard M.
Publicado no Cytometry A (2014)

Neoplastic and Non-Neoplastic Complications of Solid Organ Transplantation in Patients with Preexisting Monoclonal Gammopathy of Undetermined Significance (MGUS)

Por Goebel, Teresa E., Schiltz, Nicholas K., Woodside, Kenneth J., Pillai, Aiswarya Chandran, Caimi, Paolo F., Lazarus, Hillard M., Koroukian, Siran M., Campagnaro, Erica L.
Publicado no Clin Transplant (2015)

Acidosis Sensing Receptor GPR65 Correlates with Anti-Apoptotic Bcl-2 Family Member Expression in CLL Cells: Potential Implications for the CLL Microenvironment

Por Rosko, Ashley E, McColl, Karen S, Zhong, Fei, Ryder, Christopher B, Chang, Ming-Jin, Sattar, Abdus, Caimi, Paolo F, Hill, Brian T, Al-Harbi, Sayer, Almasan, Alexandru, Distelhorst, Clark W
Publicado no J Leuk (Los Angel) (2014)

Phase I clinical trial of the base excision repair inhibitor methoxyamine in combination with fludarabine for patients with advanced hematologic malignancies

Por Caimi, Paolo F., Cooper, Brenda W., William, Basem M., Dowlati, Afshin, Barr, Paul M., Fu, Pingfu, Pink, John, Xu, Yan, Lazarus, Hillard M., de Lima, Marcos, Gerson, Stanton L.
Publicado no Oncotarget (2017)

Hematopoietic progenitor cell harvesting is feasible after treatment with Brentuximab vedotin in CD30+ lymphoma patients who received multiple prior lines of treatment

Por Afable, Manuel, Caimi, Paolo F., Hosing, Chitra, de Lima, Marcos, Khouri, Issa, William, Basem M., Nieto, Yago, Cooper, Brenda W., Anderlini, Paolo, Gerson, Stanton L., Lazarus, Hillard M., Champlin, Richard, Popat, Uday
Publicado no Biol Blood Marrow Transplant (2015)

Outcomes of allogeneic hematopoietic stem cell transplantation for lymphomas: a single-institution experience

Por Massoud, Mira Romany, Caimi, Paolo Fabrizio, Ferrari, Nicole, Fu, Pingfu, Creger, Richard, Fox, Robert, Carlson-Barko, Joanne, Kolk, Merle, Brister, Lauren, Cooper, Brenda Wimpfheimer, Gerson, Stanton, Lazarus, Hillard Michael, de Lima, Marcos, William, Basem Magdy
Publicado no Rev Bras Hematol Hemoter (2016)

A phase 1 trial of SGN-CD70A in patients with CD70-positive diffuse large B cell lymphoma and mantle cell lymphoma

Por Phillips, Tycel, Barr, Paul M., Park, Steven I., Kolibaba, Kathryn, Caimi, Paolo F., Chhabra, Saurabh, Kingsley, Edwin C., Boyd, Thomas, Chen, Robert, Carret, Anne-Sophie, Gartner, Elaina M., Li, Hong, Yu, Cindy, Smith, David C.
Publicado no Invest New Drugs (2018)

Brentuximab vedotin plus bendamustine: a highly active first salvage regimen for relapsed or refractory Hodgkin lymphoma

Por LaCasce, Ann S., Bociek, R. Gregory, Sawas, Ahmed, Caimi, Paolo, Agura, Edward, Matous, Jeffrey, Ansell, Stephen M., Crosswell, Howland E., Islas-Ohlmayer, Miguel, Behler, Caroline, Cheung, Eric, Forero-Torres, Andres, Vose, Julie, O’Connor, Owen A., Josephson, Neil, Wang, Yinghui, Advani, Ranjana
Publicado no Blood (2018)

A Prospective Multicenter Phase 2 Study of Dose-Adjusted-EPOCH-R in Untreated MYC-Rearranged Aggressive B-cell Lymphoma

Por Dunleavy, Kieron, Fanale, Michelle A., Abramson, Jeremy S., Noy, Ariela, Caimi, Paolo Fabrizio, Pittaluga, Stefania, Parekh, Samir, Lacasce, Ann, Hayslip, John W, Jagadeesh, Deepa, Nagpal, Sunil, Lechowicz, Mary Jo, Gaur, Rakesh, Lucas, Andrea, Melani, Christopher, Roschewski, Mark, Steinberg, Seth M., Jaffe, Elaine S., Kahl, Brad, Friedberg, Jonathan W., Little, Richard F., Bartlett, Nancy L., Wilson, Wyndham H.
Publicado no Lancet Haematol (2018)